title: Bradykinin antagonists in human systems: correlation between receptor binding, calcium signalling in isolated cells, and functional activity in isolated ileum.
abstract: The determination of the relationship between ligand affinity and bioactivity is important for the understanding of receptor function in biological systems and for drug development. Several physiological and pathophysiological functions of bradykinin (BK) are mediated via the B2 receptor. In this study, we have examined the relationship between B2 receptor (soluble and membrane-bound) binding of BK peptidic antagonists, inhibition of calcium signalling at a cellular level, and in vitro inhibition of ileum contraction. Only human systems were employed in the experiments. Good correlations between the studied activities of BK antagonists were observed for a variety of different peptidic structures. The correlation coefficients (r) were in the range of 0.905 to 0.955. In addition, we analyzed the effect of the C-terminal Arg9 removal from BK and its analogs on B2 receptor binding. The ratios of binding constants (Ki(+Arg)/Ki(-Arg)) for the Arg9 containing compounds and the corresponding des-Arg9 analogs varied from about 10 to 250,000. These ratios strongly depend on the chemical structures of the compounds. The highest ratios were observed for two natural agonist pairs, BK/des-Arg9-BK and Lys0-BK/des-Arg9-Lys0-BK.
authors.affiliation: Cortech, Inc., Denver, CO 80221, U.S.A. mwieczorek@crtq.com
authors.forename: M
authors.initials: M
authors.lastname: Wieczorek
authors.forename: A
authors.initials: A
authors.lastname: Pilyavskaya
authors.forename: M
authors.initials: M
authors.lastname: Burkard
authors.forename: J S
authors.initials: JS
authors.lastname: Zuzack
authors.forename: S W
authors.initials: SW
authors.lastname: Jones
authors.forename: M D
authors.initials: MD
authors.lastname: Francis
authors.forename: V E
authors.initials: VE
authors.lastname: Beckey
authors.forename: S E
authors.initials: SE
authors.lastname: Ross
authors.forename: V S
authors.initials: VS
authors.lastname: Goodfellow
authors.forename: T D
authors.initials: TD
authors.lastname: Fitzpatrick
authors.forename: M V
authors.initials: MV
authors.lastname: Marathe
authors.forename: A
authors.initials: A
authors.lastname: Gyorkos
authors.forename: L W
authors.initials: LW
authors.lastname: Spruce
authors.forename: W M
authors.initials: WM
authors.lastname: Selig
authors.forename: J M
authors.initials: JM
authors.lastname: Stewart
authors.forename: L
authors.initials: L
authors.lastname: Gera
authors.forename: E T
authors.initials: ET
authors.lastname: Whalley
mesh_terms: D001920:Bradykinin / Q000037:antagonists & inhibitors*; D002118:Calcium / Q000378:metabolism*; D004090:Dihydromorphine / Q000494:pharmacology; D006801:Humans; D007082:Ileum / Q000378:metabolism* / Q000502:physiology; D066298:In Vitro Techniques; D018002:Receptors, Bradykinin / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D018002:Receptors, Bradykinin; D004090:Dihydromorphine; D001920:Bradykinin; D002118:Calcium